Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-026574
Filing Date
2025-09-04
Accepted
2025-09-04 16:00:17
Documents
1
Period of Report
2025-09-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5578
  Complete submission text file 0001641172-25-026574.txt   7190
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address NO. 28, JALAN EKOFLORA 1/13 TAMAN EKOFLORA, 81100 JOHOR BAHRU JOHOR Malaysia 00000
Business Address
Kua Khai Loon (Reporting) CIK: 0002081556 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 251293280